secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001104659-25-084053
Event type: debt
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax issues $225M 4.625% convertible notes due 2031, exchanges $148.7M of 2027 notes
--------------------------------------------------------------------------------

- Issued $225M principal of 4.625% Convertible Senior Notes due 2031; initial conversion price ~$11.14 (27.5% premium).
- Exchanged ~$175.3M of new notes for ~$148.7M of existing 5.00% 2027 notes; $49.7M for cash.
- Notes mature Sept 1, 2031; interest payable semi-annually; redeemable by company after Sept 5, 2028 if stock >130% of conversion price.
- Maximum dilution: 25,743,690 shares upon conversion at max conversion rate $8.74 per share.
- Exchange portion unregistered under Section 3(a)(9); shares upon conversion also exempt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925084053/0001104659-25-084053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925084053/tm2524511d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-084053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer